A multidisciplinary, shared care clinic using personalized medicine and coordinated care in patients with concomitant type 2 diabetes and cardiovascular disease. Protocol and baseline characteristics
© 2024 The Authors..
Background: Concomitant type 2 diabetes (T2DM) and cardiovascular disease (CVD) is frequent with a poor prognosis with high risk of comorbidities. Strict risk factor control reduces the risk for complications - yet many people do not achieve treatment targets. The complexity and fragmentation of the healthcare system may, together with the vulnerability of these patients, be a reason.
Objective: The purpose of this paper is to describe the protocol of a non-randomized interventional pilot study testing the feasibility and effect of a multidisciplinary, shared care clinic using personalized medicine and coordinated care in people living with concomitant T2D and CVD.
Methods: Participants were included from the Holbaek area in Denmark. People suffered from T2DM and CVD and were dysregulated regarding to HbA1c, cholesterol, micro/macroalbuminuaria or blood pressure. Participants went through a thorough evaluation to identify their needs and resources and received consultations every three months for one year.
Results: A total of 63 participants with T2DM and CVD were enrolled in the clinic. The participants had a mean age of 69 years and a BMI of 30.9 kg/m2. Almost 50 % had heart failure, 95 % dyslipidemia and 91 % hypertension. Around 54 % received GLP-1 agonists and 39 % received SGLT-2-inhibitors.
Perspectives: To our knowledge, a similar study with a multidisciplinary, shared care, outpatient clinic treating people living with concomitant T2DM and CVD, has not been performed previously. This study will provide information about the feasibility and efficacy of a multidisciplinary clinic based on changes in cardiovascular risk factors and medication.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Preventive medicine reports - 38(2024) vom: 01. Jan., Seite 102594 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pontoppidan, Julie Rye Noer [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cardiovascular Diseases |
|---|
| Anmerkungen: |
Date Revised 31.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.pmedr.2024.102594 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367743736 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367743736 | ||
| 003 | DE-627 | ||
| 005 | 20240131232127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240129s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pmedr.2024.102594 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1276.xml |
| 035 | |a (DE-627)NLM367743736 | ||
| 035 | |a (NLM)38283962 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pontoppidan, Julie Rye Noer |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A multidisciplinary, shared care clinic using personalized medicine and coordinated care in patients with concomitant type 2 diabetes and cardiovascular disease. Protocol and baseline characteristics |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 31.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. | ||
| 520 | |a Background: Concomitant type 2 diabetes (T2DM) and cardiovascular disease (CVD) is frequent with a poor prognosis with high risk of comorbidities. Strict risk factor control reduces the risk for complications - yet many people do not achieve treatment targets. The complexity and fragmentation of the healthcare system may, together with the vulnerability of these patients, be a reason | ||
| 520 | |a Objective: The purpose of this paper is to describe the protocol of a non-randomized interventional pilot study testing the feasibility and effect of a multidisciplinary, shared care clinic using personalized medicine and coordinated care in people living with concomitant T2D and CVD | ||
| 520 | |a Methods: Participants were included from the Holbaek area in Denmark. People suffered from T2DM and CVD and were dysregulated regarding to HbA1c, cholesterol, micro/macroalbuminuaria or blood pressure. Participants went through a thorough evaluation to identify their needs and resources and received consultations every three months for one year | ||
| 520 | |a Results: A total of 63 participants with T2DM and CVD were enrolled in the clinic. The participants had a mean age of 69 years and a BMI of 30.9 kg/m2. Almost 50 % had heart failure, 95 % dyslipidemia and 91 % hypertension. Around 54 % received GLP-1 agonists and 39 % received SGLT-2-inhibitors | ||
| 520 | |a Perspectives: To our knowledge, a similar study with a multidisciplinary, shared care, outpatient clinic treating people living with concomitant T2DM and CVD, has not been performed previously. This study will provide information about the feasibility and efficacy of a multidisciplinary clinic based on changes in cardiovascular risk factors and medication | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cardiovascular Diseases | |
| 650 | 4 | |a Comorbidity | |
| 650 | 4 | |a Diabetes Mellitus | |
| 650 | 4 | |a Pilot Projects | |
| 650 | 4 | |a Prospective Studies | |
| 650 | 4 | |a Risk Factors | |
| 650 | 4 | |a Type 2 | |
| 650 | 4 | |a Vulnerable Patients | |
| 700 | 1 | |a Nielsen, Emil Eik |e verfasserin |4 aut | |
| 700 | 1 | |a Olsen, Michael Hecht |e verfasserin |4 aut | |
| 700 | 1 | |a Skjødt, Michael Kriegbaum |e verfasserin |4 aut | |
| 700 | 1 | |a Christensen, Jesper Olund |e verfasserin |4 aut | |
| 700 | 1 | |a Raymond, Ilan Esra |e verfasserin |4 aut | |
| 700 | 1 | |a Møller, Sara Hedlund |e verfasserin |4 aut | |
| 700 | 1 | |a Soja, Anne Merete Boas |e verfasserin |4 aut | |
| 700 | 1 | |a Gæde, Peter Haulund |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Preventive medicine reports |d 2014 |g 38(2024) vom: 01. Jan., Seite 102594 |w (DE-627)NLM244792496 |x 2211-3355 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g day:01 |g month:01 |g pages:102594 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pmedr.2024.102594 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2024 |b 01 |c 01 |h 102594 | ||